Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PBI
PBI logo

PBI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Pitney Bowes Inc (PBI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
17.040
1 Day change
1.43%
52 Week Range
18.250
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Pitney Bowes is not a strong buy right now for a beginner long-term investor, even with $50,000-$100,000 to invest. The stock has some constructive long-term turnaround signals, but the current setup is mixed and does not justify an aggressive buy today. If forced to choose right now, hold is the better call because the price is near support, but momentum is weakening and insider/hedge fund selling is a real negative.

Technical Analysis

PBI is in a short-term fragile trend despite a constructive moving-average structure. The SMA_5 > SMA_20 > SMA_200 setup is bullish on a longer trend basis, but the MACD histogram is negative and expanding, which shows near-term momentum is deteriorating. RSI_6 at 33.07 is weak but not yet deeply oversold. Price at 17.00 is just above S1 at 16.796 and below the pivot at 17.43, so the stock is trading in the lower half of its range. This suggests the trend is not broken long-term, but the current entry is not especially attractive for an impatient buyer.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is bullish overall. The put-call ratios are low, meaning traders are leaning toward calls rather than puts. Open interest put-call ratio of 0.22 and option volume put-call ratio of 0.43 both point to a positive bias. However, implied volatility at 43.3 is above historical volatility at 29.39, so options are pricing in notable movement. That supports bullish sentiment, but not a clean low-risk long-term entry signal.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
7

Positive Catalysts

  • Citizens, BofA, Goldman Sachs, and Truist all raised price targets recently, reflecting improving confidence in the turnaround. Citizens expects a lower cost of capital over time and cites positive developments after earnings, debt maturity extension, and potential postal-service-related tailwinds. BofA says the company is beginning to turn a corner with stabilizing revenue declines, cost take-out, and share buybacks. Goldman and Truist also noted better revenue stability, margin improvement, and a clearer path forward. The absence of recent negative news is also supportive.

Neutral/Negative Catalysts

  • There has been no new news in the past week, so there is no fresh catalyst driving the stock higher now. Hedge funds are selling heavily, and insider selling has surged sharply, which is a meaningful negative for near-term confidence. The stock also recently showed a regular market decline of 4.21% in the provided data, indicating weak immediate price action. The company remains in a turnaround phase, which is not ideal for a beginner seeking straightforward long-term quality.

Financial Performance

No latest-quarter financial snapshot was available because the provided financial data returned an error. From the analyst commentary, the latest quarter appears to have shown improving trends: Q1 revenue declined 3% year over year, which was better than the prior quarter, and operating margins expanded significantly due to cost controls. Guidance was also modestly raised, suggesting improving operational momentum in the latest quarter season, likely Q1 2026 based on the analyst notes.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment has improved over the last few months. Citizens remains Outperform and raised its target to $19, BofA upgraded to Neutral with a target of $16.50, Goldman moved its target up to $15.20 while staying Neutral, and Truist raised its target to $15 and kept Hold. The Wall Street pros view is mixed-to-positive: bulls point to revenue stabilization, margin expansion, buybacks, debt improvements, and leadership strength, while bears/neutral analysts believe the stock already reflects much of the turnaround. Overall, the analyst trend is improving, but the consensus is still cautious rather than strongly bullish.

Wall Street analysts forecast PBI stock price to fall
3 Analyst Rating
Wall Street analysts forecast PBI stock price to fall
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 16.800
sliders
Low
9.43
Averages
11.14
High
13
Current: 16.800
sliders
Low
9.43
Averages
11.14
High
13
Citizens
maintain
$17 -> $19
AI Analysis
2026-06-05
Reason
Citizens
Price Target
$17 -> $19
AI Analysis
2026-06-05
maintain
Reason
Citizens raised the firm's price target on Pitney Bowes to $19 from $17 and keeps an Outperform rating on the shares. The firm cites a "number of positive developments" since the company's earnings call on May 6 for the target boost. On May 13, Fitch initiated coverage of Pitney Bowes' debt with a BB- rating, which is a notch above the ratings from the other major ratings agencies, the analyst tells investors in a research note. Citizens believes this will lower the company's cost of capital over time. In addition, Pitney extended the maturity of its term loan while the Postal Service listed its proposed change for presorted mail, including a 6.3% increase in the delta between five-digit volumes presort vendors like Pitney Bowes and the three-digit spreads that some customers can achieve themselves, adds the firm.
BofA
Underperform
to
Neutral
upgrade
2026-05-11
Reason
BofA
Price Target
2026-05-11
upgrade
Underperform
to
Neutral
Reason
As previously reported, BofA upgraded Pitney Bowes to Neutral from Underperform with a price target of $16.50, up from $9.50, following better-than-expected Q1 results. Given its view that Pitney Bowes is \"beginning to turn a corner\" on stabilizing revenue declines, coupled with meaningful cost take-out since 2024 and robust share buybacks, the firm is more confident on operating earnings growth and capital return, but sees shares as discounting much of a potential turnaround with the stock up about 50% year-to-date, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PBI
Unlock Now

People Also Watch